9 research outputs found

    Research priorities in hypertrophic cardiomyopathy: report of a Working Group of the National Heart, Lung, and Blood Institute.

    Get PDF
    Hypertrophic cardiomyopathy (HCM) is a myocardial disorder characterized by left ventricular (LV) hypertrophy without dilatation and without apparent cause (ie, it occurs in the absence of severe hypertension, aortic stenosis, or other cardiac or systemic diseases that might cause LV hypertrophy). Numerous excellent reviews and consensus documents provide a wealth of additional background.1–8 HCM is the leading cause of sudden death in young people and leads to significant disability in survivors. It is caused by mutations in genes that encode components of the sarcomere. Cardiomyocyte and cardiac hypertrophy, myocyte disarray, interstitial and replacement fibrosis, and dysplastic intramyocardial arterioles characterize the pathology of HCM. Clinical manifestations include impaired diastolic function, heart failure, tachyarrhythmia (both atrial and ventricular), and sudden death. At present, there is a lack of understanding of how the mutations in genes encoding sarcomere proteins lead to the phenotypes described above. Current therapeutic approaches have focused on the prevention of sudden death, with implantable cardioverter defibrillator placement in high-risk patients. But medical therapies have largely focused on alleviating symptoms of the disease, not on altering its natural history. The present Working Group of the National Heart, Lung, and Blood Institute brought together clinical, translational, and basic scientists with the overarching goal of identifying novel strategies to prevent the phenotypic expression of disease. Herein, we identify research initiatives that we hope will lead to novel therapeutic approaches for patients with HCM

    Health behavior practice among understudied Chinese and Filipino Americans with cardiometabolic diseases

    No full text
    Lifestyle modification and health behavior practice among the individuals with cardiometabolic diseases (CMD) are important for secondary prevention and disease control. This study was designed to investigate and compare health behavior practices among Chinese and Filipino Americans with CMD. Three hundred seventy-four Asian Americans (211 Chinese and 163 Filipino) who reside in the greater Philadelphia region and had either CMD or no identified disease were included in the study. Information on smoking, alcohol intake, physical activity, and salt and sweets consumption was collected, as well as demographic and acculturative characteristics. Of the 374 participants, 241 (64.4%) had CMD and 133 (35.6%) had no identified disease. The majority of Chinese and Filipino Americans with CMD failed to meet the dietary and physical activity guidelines, and only a small percentage of them restricted their amount of salt added to food and amount of sweets consumption. Compared to participants with no disease, Chinese participants with CMD were more likely to “never” add salt to food (AOR 4.42 compared to “frequently”). Filipino Americans with CMD were less likely to be those who “never” consume sweets than those who frequently consume sweets (AOR = 0.12). Among the participants with CMD, Chinese participants with CMD were less likely to restrict drinking (AOR 0.11) than Filipinos with CMD. The findings suggest that tailored interventions for Chinese and Filipino Americans with CMD should be developed to enhance their compliance to behavioral guidelines to prevent further disease progression and complications. Keywords: Cardiometabolic diseases, Chinese, Filipinos, Health behaviors, Secondary preventio

    Obligatory role of neuronal nitric oxide synthase in the heart\u27s antioxidant adaptation with exercise

    No full text
    Excessive oxidative stress in the heart results in contractile dysfunction. While antioxidant therapies have been a disappointment clinically, exercise has shown beneficial results, in part by reducing oxidative stress. We have previously shown that neuronal nitric oxide synthase (nNOS) is essential for cardioprotective adaptations caused by exercise. We hypothesize that part of the cardioprotective role of nNOS is via the augmentation of the antioxidant defense with exercise by positively shifting the nitroso-redox balance. Our results show that nNOS is indispensable for the augmented anti-oxidant defense with exercise. Furthermore, exercise training of nNOS knockout mice resulted in a negative shift in the nitroso-redox balance resulting in contractile dysfunction. Remarkably, overexpressing nNOS (conditional cardiac-specific nNOS overexpression) was able to mimic exercise by increasing VO2max. This study demonstrates that exercise results in a positive shift in the nitroso-redox balance that is nNOS-dependent. Thus, targeting nNOS signaling may mimic the beneficial effects of exercise by combating oxidative stress and may be a viable treatment strategy for heart disease

    Science Applications of Phased Array Radars

    No full text
    Abstract Phased array radars (PARs) are a promising observing technology, at the cusp of being available to the broader meteorological community. PARs offer near-instantaneous sampling of the atmosphere with flexible beam forming, multifunctionality, and low operational and maintenance costs and without mechanical inertia limitations. These PAR features are transformative compared to those offered by our current reflector-based meteorological radars. The integration of PARs into meteorological research has the potential to revolutionize the way we observe the atmosphere. The rate of adoption of PARs in research will depend on many factors, including (i) the need to continue educating the scientific community on the full technical capabilities and trade-offs of PARs through an engaging dialogue with the science and engineering communities and (ii) the need to communicate the breadth of scientific bottlenecks that PARs can overcome in atmospheric measurements and the new research avenues that are now possible using PARs in concert with other measurement systems. The former is the subject of a companion article that focuses on PAR technology while the latter is the objective here.Department of Defense (DoD)Department of Energy (DOE)National Aeronautics and Space Administration (NASA)National Ocean and Atmospheric Administration (NOAA)National Science Foundation (NSF

    Disease Modification in Epilepsy: From Animal Models to Clinical Applications

    No full text
    corecore